Skip to main content
. Author manuscript; available in PMC: 2017 Apr 7.
Published in final edited form as: Mod Pathol. 2016 Oct 7;30(1):69–84. doi: 10.1038/modpathol.2016.161

Figure 6. Comparison of the frequencies of mutations affecting selected genes in carcinoma-associated microglandular adenoses/atypical microglandular adenoses and acinic cell carcinomas, as a group, and in ER-positive/HER2-negative, HER2-positive and triple-negative breast cancers from The Cancer Genome Atlas.

Figure 6

ER, estrogen receptor.